Log in to save to my catalogue

Obesity and contraceptive use: impact on cardiovascular risk

Obesity and contraceptive use: impact on cardiovascular risk

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a229b857a0db4091941e230d5d871ab8

Obesity and contraceptive use: impact on cardiovascular risk

About this item

Full title

Obesity and contraceptive use: impact on cardiovascular risk

Publisher

England: John Wiley & Sons, Inc

Journal title

ESC Heart Failure, 2022-12, Vol.9 (6), p.3761-3767

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Obesity and oestrogen containing contraceptive products are well‐known independent cardiovascular risk factors. However, a significant number of obese women continue to receive prescriptions of hormonal products that contain oestrogens for their contraception. We have conducted a narrative review to discuss the latest evidence, ongoing research, an...

Alternative Titles

Full title

Obesity and contraceptive use: impact on cardiovascular risk

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a229b857a0db4091941e230d5d871ab8

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a229b857a0db4091941e230d5d871ab8

Other Identifiers

ISSN

2055-5822

E-ISSN

2055-5822

DOI

10.1002/ehf2.14104

How to access this item